1. Bharti Airtel:
This telecom company rose 1.7% on May 18 after its management signaled further room for telecom price hikes. The company feels that plans are too cheap: Executive Vice Chairman Gopal Vittal said that “the pricing architecture in this country is broken” and that higher-end users are paying too little.
In Q4FY26, revenue grew 15.7% YoY to Rs 55,383 crore, driven by premium smartphone users, broadband growth, and strong performance in Africa. Net profit rose 18%, supported by growth in postpaid subscribers and higher-paying smartphone users.
The company added 5.8 million 4G and 5G smartphone users and nearly 815,000 postpaid subscribers. Continued migration away from lower-priced plans also helped average revenue per user (ARPU) jump nearly 5% to Rs 257. By comparison, Jio’s Q4FY26 ARPU is lower, at Rs 214, highlighting Airtel’s stronger premium subscriber mix.
The company is also making a larger push into digital infrastructure through Nxtra, its data center subsidiary. Nxtra plans to build 1 gigawatt of data center capacity over the next few years as demand rises from AI applications, cloud storage, and digital services. To fund this expansion, Nxtra recently raised $1 billion from investors including Alpha Wave Global and Carlyle, with Bharti Airtel also participating in the fundraising round.
Management also highlighted how Airtel’s broadband bundling strategy is helping customer stickiness. Shashwat Sharma, MD & CEO of Airtel India, said, “Customers subscribing to both Airtel mobile and home Wi-Fi services are nearly 50% less likely to leave the network.”
ICICI Direct reiterated its 'Buy' rating, but with a lower target price of Rs 2,350. The brokerage said Airtel continues to maintain industry-leading ARPU, wireless margins, and cash flows. However, it lowered the target price after slower near-term ARPU growth and delayed tariff hikes. Even then, ICICI expects Airtel’s ARPU to rise to Rs 309 by FY28 as future tariff hikes and premium customer additions boost revenue growth.
2. Samvardhana Motherson International (SAMIL):
The stock of this auto parts & equipment manufacturer climbed to a fresh 52-week high of Rs 139 on May 22 following a blockbuster Q4FY26 performance. Net profit surged 46.2% YoY to Rs 1,497.1 crore, propelled by a more premium product mix and better factory utilization. Revenue also advanced 9.2% to Rs 34,309.3 crore, driven by strong global demand and increasing value of parts supplied per vehicle. The stock appears on a screener for companies with rising net cash flows.
Its quarterly revenue and net profit surpassed Trendlyne’s Forecaster estimates by 4.6% and 15.1%, respectively. This global growth was supported by the smooth integration of Japan-based Atsumitec, in which the company acquired a 95% stake in 2025. Atsumitec’s high-precision auto components have further strengthened SAMIL’s relationship with major Japanese automakers such as Honda, Toyota, and Suzuki.
While the Middle East crisis triggered sharp spikes in raw polymer prices and global shipping freight, SAMIL’s unique footprint kept it well-insulated from the chaos. Vice Chairman Laksh Vaaman said, "Motherson’s business model is designed to navigate such cycles. Our globally local manufacturing strategy remains one of the key strengths. We manufacture in or near the markets we serve which substantially reduces dependence on long distance supply chains. As a result, disruptions arriving from Red Sea shipping challenges and broader geopolitical tensions have had minimal impact on our operations."
For FY27, SAMIL rolled out a Rs 6,000 crore capex plan. CFO Gulshan Pahuja noted that this capex will be split equally between maintenance and growth, with a stronger focus on emerging areas like consumer electronics. Management expects long-term growth to be supported by a $96 billion order book, including a growing aerospace pipeline worth $1.6 billion that will be executed over the next 5-8 years. The company sees further expansion in this segment, backed by India’s large aerospace market potential.
ICICI Securities maintained a ‘Buy’ rating and raised the target price to Rs 170. The brokerage believes SAMIL’s diversified portfolio better insulates it from global market volatility compared to its peers, supported by a strong order book in non-automotive segments such as aerospace and consumer electronics.
3. GE Vernova T&D India:
Thispower transmission & distribution company’s shares rose 11.8% over the past week after it reported strongQ4FY26 results on May 18. Net profit nearly doubled, while revenue increased 42% YoY. Strong execution in transmission projects, better operating leverage, and an improved product mix supported growth. EBITDA margin expanded 530 basis points to 27.2%, the highest quarterly margin in the company’s history.
The main driver was a sharp jump in order inflows. Q4 bookings nearly tripled to Rs 8,610 crore, taking the order backlog to about Rs 21,400 crore. Key wins included High-Voltage Direct Current (HVDC) projects fromAdani Energy Solutions andPower Grid Corp. About 98% of the order book now comes from private companies, central utilities, and public sector undertakings. State utility exposure is just 2%, which reduces non-payment risk.
Management expects data centres to become a long-term growth driver. CEO Sandeep Zanzariasaid India’s data centre market remains “not that big” today but may “grow meaningfully in 4–5 years.” This growth can increase demand for high-voltage transmission equipment and grid solutions.
The company also announced a capex plan of over Rs 1,000 crore through 2028. CFO Sushil Kumarsaid, “We will self-fund this capex program, which will expand our manufacturing capacity.” The investment supports local production of key HVDC system parts in India. This shift can lower import dependence and reduce costs over time.
Commodity price inflation and reliance on imported sub-components are still challenges, especially in large transmission and HVDC projects. Management manages these risks through price escalation clauses in transformer contracts. It describes localisation as a “long journey” because domestic supply chains for advanced hardware remain limited.
Following the rally, brokerage Prabhudas Lilladherdowngraded the stock to ‘Accumulate’ from ‘Buy,’ citing limited upside after a 162.9% surge over the past year. While the brokerage praised the strong execution and order pipeline, it cautioned that current valuations already reflect these gains.
4. Mankind Pharma:
This pharmaceutical company surged 3.7% on Wednesday after reporting strong Q4FY26 results. Revenue grew 11.8% YoY, while net profit jumped 30.4%, with both metrics beating Forecaster estimates. CEO Sheetal Arora said growth was “supported by improving prescription strength, healthy volume expansion, and strong brand traction across multiple therapies.”
The domestic business contributes over 80% of revenue, with chronic therapies continuing to gain share, led by cardiac and anti-diabetic segments. Consumer healthcare also maintained strong momentum, driven by brands such as Manforce, Prega News, Gas-O-Fast, and Nimulid. Profitability improved sharply during the quarter, with adjusted EBITDA margin expanding 400 basis points to 27.1%. Vice Chairman & MD Rajeev Juneja said, “We expect FY27 to be a much better year as compared to FY26 for all our businesses.”
Exports grew a modest 4.2% YoY due to geopolitical disruptions, though management remains optimistic about recovery in FY27. The company received EU certification for its Udaipur and Ambernath facilities, which should support expansion into semi-regulated markets. President Strategy Prakash Agarwal expects “high double-digit growth” in international business going forward despite near-term headwinds.
The company guided FY27 adjusted EBITDA margins at 25.5–26.5%, after factoring in the impact of a higher effective tax rate following the expiry of certain tax benefits. CFO Ashutosh Dhawan said capex will rise to 6–7% of revenue in FY27, largely towards a new biotech facility in Vadodara to support future specialty and biologics growth.
Motilal Oswal maintains a ‘Buy’ rating on the stock with a target price of Rs 2,640. The brokerage expects recovery in the domestic business, scaling up of the Bharat Serum and Vaccines portfolio, and continued traction in chronic therapies to drive growth. It projects revenue CAGR of 13% over FY27–28, supported by new launches and improving profitability.
5. JSW Energy:
This electric utilities stock jumped 7.5% last week after the company sold a 1% stake of JSW Steel for Rs 3,150 crore in a bulk deal on May 18. JSW Energy now holds a 1.8% stake in the latter. On Thursday, the board approved a Rs 4,000 crore fundraise through a qualified institutional placement of equity shares. The company will use these funds to expand its power generation capacity.
Discussing future plans, Joint MD and CEO Sharad Mahendra said, “We are looking to add about 3 gigawatt (GW) capacity and a capex spend of around Rs 20,000 crore during FY27.” This will take the company’s total installed capacity to 16.5 GW in the next financial year.
Renewable energy (RE) now makes up 58% of existing capacity and 77% of projects under construction, marking a shift toward clean power. The company is also expanding its battery energy storage business with a 29.6 gigawatt-hour pipeline. To control costs, JSW Energy is building its own battery assembly units and improving its supply chain.
The company reported healthy Q4FY26 results. Revenue climbed 38.7% YoY as early summers drove power demand higher. Thermal power generation improved after the company acquired KSK Mahanadi, ramped up Utkal Unit-II, and signed a long-term power supply deal with JSW Steel. Meanwhile, adding new wind, solar, and hydro plants, along with buying assets from O2 Power, boosted RE generation.
EBITDA grew 87%, and margins expanded by 12.2 percentage points amid lower fuel transport costs, higher sales from the profitable RE segment, and better merchant pricing. However, net profit dropped 48.1% due to increased depreciation expenses as the company expanded its capacity 1.6 times over the last 15 months.
Following the results, Prabhudas Lilladher retained a ‘Buy’ rating on JSW Energy with a target price of Rs 644, implying a 16.8% upside. The brokerage believes the company is becoming a high-growth integrated power platform. Expansion in RE capacity, strong cash flow from thermal plants, and a growing focus on energy storage support this positive view. Analysts expect the firm to deliver annual revenue growth of 13.4% and net profit growth of 7.8% through FY28.
Trendlyne's analysts identify stocks that are seeing interesting price movements, analyst calls, or new developments. These are not buy recommendations.
